Search Results - College of Psychiatric & Neurologic Pharmacists

Benzodiazepine use, misuse, and abuse: A review by Schmitz, Allison

“…Benzodiazepine (BZD) abuse has reached epidemic levels and results in poor outcomes, particularly when combined with concomitant central nervous system…”
Get full text

Major depressive disorder in children and adolescents by Mullen, Sandra

“…Major depressive disorder (MDD) is one of the most common psychiatric disorders of childhood and adolescence, but because of symptom variation from the adult…”
Get full text

Donepezil-induced QTc prolongation: A case report by Vogel, Samantha M, Mican, Lisa M, Smith, Tawny L

“…Several psychoactive medications are known to cause QTc prolongation. Patient factors also increase the risk for QTc prolongation, including bradycardia,…”
Get full text

Levocarnitine for valproate-induced hyperammonemia in the psychiatric setting: A case series and literature review by Brown, Lauren M, Cupples, Nicole, Moore, Troy A

“…Hyperammonemia is a potential adverse effect of valproic acid (VPA) therapy, which is often asymptomatic but can lead to severe, life-threatening…”
Get full text

Evaluation of obsessive-compulsive symptoms in relation to smartphone use by Kempf, Carly A, Ehrhard, Kimberly A, Stoner, Steven C

“…The use of smartphones throughout the United States continues to rise. Although smartphones have increased our capacity to access information, there is concern…”
Get full text

Review of the many faces of synthetic cannabinoid toxicities by Alipour, Azita, Patel, Puja Baldev, Shabbir, Zaheera, Gabrielson, Stephen

“…Synthetic cannabinoids (SCs) are psychoactive substances that are gaining popularity for their availability and lack of detection by standardized drug tests…”
Get full text

Antimicrobial-induced cognitive side effects by Warstler, Amanda, Bean, Jennifer

“…Antimicrobial-induced cognitive side effects are often overlooked or underreported. Literature often reports symptoms of antimicrobial-induced cognitive…”
Get full text

Role of antidepressants in the treatment of adults with anorexia nervosa by Marvanova, Marketa, Gramith, Kirstin

“…Anorexia nervosa (AN) is a severe psychiatric disorder that is difficult to treat and is associated with frequent relapses and high mortality rates…”
Get full text

Pharmacologic management of behavioral and psychological symptoms of major neurocognitive disorder by Mathys, Monica

“…Behavioral and psychological symptoms of dementia (BPSD) occur in approximately 80% of patients who receive a diagnosis of major neurocognitive disorder…”
Get full text

The effects of ketamine on suicidality across various formulations and study settings by Dadiomov, David, Lee, Kelly

“…Suicidality and self-injurious behavior afflict patients with a wide variety of psychiatric illnesses. Currently, there are few pharmacologic treatments for…”
Get full text

Positioning psychiatric pharmacists to improve mental health care by Dopheide, Julie A, Werremeyer, Amy, Haight, Robert J, Gutierrez, Cynthia A, Williams, Andrew M

“…Psychiatric pharmacy continues to grow and look to the future with a focus on helping individuals recover from mental health and substance use disorders. The…”
Get full text

Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature by Grady, Sarah E, Marsh, Travis A, Tenhouse, Allison, Klein, Kelsey

“…Over the past decade, ketamine has been studied for major depressive disorder and bipolar depression. Ketamine is believed to exert its antidepressant…”
Get full text

A review of medical marijuana for the treatment of posttraumatic stress disorder: Real symptom re-leaf or just high hopes? by Shishko, Ilona, Oliveira, Rosana, Moore, Troy A, Almeida, Kenneth

“…The incidence of posttraumatic stress disorder (PTSD) is common within the population and even more so among veterans. Current medication treatment is limited…”
Get full text

Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements by Silvia, Richard J, Lee, Kelly C, Payne, Gregory H, Ho, Jessica, Cobb, Carla, Ansara, Elayne D, Ross, Clint A

“…A 2019 survey identified significant variability of practice characteristics among outpatient psychiatric pharmacists (OPPs). No published model establishes…”
Get full text

Lithium toxicity following Roux-en-Y gastric bypass: Mini review and illustrative case by Ayub, Shahana, Saboor, Sundas, Usmani, Sadia, Javed, Sana, Tonpouwo, Gauvain Kankeu, Ahmed, Saeed

“…Abstract Lithium is among the mainstays of treatment for bipolar disorder. Bariatric surgery can considerably change the oral bioavailability of drugs,…”
Get full text

Pharmacotherapy treatment of stimulant use disorder by Liu, Mei T.

“…Abstract Stimulant use disorder (SUD) is a public health problem in the United States that is associated with increased morbidity and mortality. Psychosocial…”
Get full text

Essential oil of lavender in anxiety disorders: Ready for prime time? by Malcolm, Benjamin J, Tallian, Kimberly

“…Anxiety disorders are some of the most common psychiatric disorders, with potentially debilitating consequences on individual function. Existing…”
Get full text

Second-generation antipsychotic use in borderline personality disorder: What are we targeting? by Wasylyshen, Adrian, Williams, Andrew M

“…Borderline personality disorder (BPD) is a personality disorder plagued with high rates of psychotropic polypharmacy. Estimates show that second-generation…”
Get full text

Overview of pharmacogenomic testing in clinical practice by Gross, Tonya, Daniel, Jeremy

“…Pharmacogenomic tests relevant to neuropsychiatric medications have been clinically available for more than a decade, but the utility of regular testing is…”
Get full text

Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone by Mailloux, Lindsay M, Haas, Matthew T, Larew, Janel M, DeJongh, Beth M

“…Physician-pharmacist collaborative practice models (PPCPM) decrease barriers and increase access to medications for opioid use disorder (MOUD) but are not…”
Get full text